Gregory Scott Duncan
CHIEF EXECUTIVE OFFICER at Dogwood Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: CorMedix Inc., 3 years.
CorMedix Inc.
Director
Dogwood Therapeutics Inc.
Director · CHIEF EXECUTIVE OFFICER
Chief executive roles
Dogwood Therapeutics Inc.
· CHIEF EXECUTIVE OFFICER
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 26, 2026 | CorMedix Inc. | Grant or award | +30,453 | — | — |
| Sep 16, 2025 | CorMedix Inc. | Option exercise | +13,333 | $8.32 | $110,931 |
| Jan 17, 2025 | CorMedix Inc. | Grant or award | +25,000 | — | — |
| Aug 17, 2023 | Dogwood Therapeutics Inc. | Open-market purchase | +25,000 | $1.25 | $31,250 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.